What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Cancer
Markus M. Lerch focuses on Internal medicine, Pancreatitis, Pancreas, Gastroenterology and Pathology.
His Internal medicine study combines topics in areas such as Endocrinology, Hereditary pancreatitis and Oncology.
His research integrates issues of Trypsinogen and Acute pancreatitis in his study of Pancreatitis.
His Pancreas research incorporates elements of Extracellular, Guideline, Metastasis and Ceruletide.
His study on Gastroenterology also encompasses disciplines like
- Gene mutation which connect with Autosomal dominant trait,
- MEDLINE that intertwine with fields like Intensive care medicine.
His study in Pathology is interdisciplinary in nature, drawing from both Cancer and Stem cell.
His most cited work include:
- International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. (918 citations)
- Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial (911 citations)
- Cohort Profile: The Study of Health in Pomerania (700 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Pancreatitis, Gastroenterology, Acute pancreatitis and Endocrinology.
His research in Internal medicine intersects with topics in Hereditary pancreatitis, Oncology and Study of Health in Pomerania.
His biological study spans a wide range of topics, including Trypsinogen, Disease, Pathology and Pancreas.
Particularly relevant to Pancreatic duct is his body of work in Gastroenterology.
His Acute pancreatitis research integrates issues from Immunology and Intensive care medicine.
As part of his studies on Pancreatic cancer, Markus M. Lerch often connects relevant subjects like Cancer research.
He most often published in these fields:
- Internal medicine (43.53%)
- Pancreatitis (33.61%)
- Gastroenterology (20.39%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (43.53%)
- Pancreatitis (33.61%)
- Gastroenterology (20.39%)
In recent papers he was focusing on the following fields of study:
Internal medicine, Pancreatitis, Gastroenterology, Acute pancreatitis and Pancreatic cancer are his primary areas of study.
His Internal medicine research is multidisciplinary, incorporating perspectives in Diabetes mellitus, Endocrinology, Oncology and Study of Health in Pomerania.
His research integrates issues of Hereditary pancreatitis, Bioinformatics, Pancreas and Disease, Pathology in his study of Pancreatitis.
His study in Single-nucleotide polymorphism extends to Gastroenterology with its themes.
His research is interdisciplinary, bridging the disciplines of Immunology and Acute pancreatitis.
His work in Pancreatic cancer is not limited to one particular discipline; it also encompasses Cancer research.
Between 2015 and 2021, his most popular works were:
- European evidence-based guidelines on pancreatic cystic neoplasms (333 citations)
- United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU) (216 citations)
- PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study (205 citations)
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
